Skip to main content
SpringerLink
Log in

Medical Approaches to Preventing Vision Loss from Diabetic Retinopathy

  • Chapter
Diabetic Renal-Retinal Syndrome

  • 80 Accesses

Abstract

Data from the Diabetic Retinopathy Study [1] and the Early Treatment Diabetic Retinopathy Study [2], demonstrated the efficacy of photocoagulation treatment in preventing visual loss associated with proliferative diabetic retinopathy. However, clinical trial data demonstrating the efficacy of medical interventions for this disease have only become available within the last decade. Nonsurgical interventions prior to the development of severe retinopathy are important because photocoagulation is associated with complications and in some cases may not prevent the progression of retinopathy, resulting in visual loss. The purpose of this review is to examine data from ongoing and completed randomized controlled clinical trials of medical interventions to reduce the progression of retinopathy and loss of vision in persons with diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Diabetic Retinopathy Study Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of Diabetic Retinopathy Study (DRS) findings. DRS Report No. 8. Ophthalmology 1981; 88: 583–600.

    Google Scholar 

  2. ETDRS Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985; 103: 1796–1806.

    Article  Google Scholar 

  3. University Group Diabetes Program. Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VIII. Evaluation of insulin therapy: final report. Diabetes 1982; 31: 1–81.

    Article  Google Scholar 

  4. Klein R, Klein BEK, Moss SE, Davis MD, DeMets SL. Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy. JAMA 1988; 260: 2864–2871.

    Article  PubMed  CAS  Google Scholar 

  5. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IV. Diabetic macular edema. Ophthalmology 1984; 91: 1464–1474.

    PubMed  CAS  Google Scholar 

  6. The Kroc Collaborative Study Goup. Diabetic retinopathy after two years of intensified insulin treatment: follow-up of The Kroc Collaborative Study. JAMA 1988; 260: 37–41.

    Article  Google Scholar 

  7. Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group. Two-year experience with continuous subcutaneous insulin infusion in relation to retinopathy and neuropathy. Diabetes 1985; 34: 74–79.

    Article  PubMed  Google Scholar 

  8. Dahl-Jorgensen K, Brinchmann-Hansen O, Hanssen KF, Ganes T, Kierulf P, Smeland E, Sandvik L, Aagenaes O. Effect of near normoglycemia for two years on progression of early diabetic retinopathy, nephropathy, and neuropathy: The Oslo Study. Br Med J 1986; 293: 1995–1999.

    Article  Google Scholar 

  9. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977–986.

    Article  Google Scholar 

  10. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus: The Diabetes control and Complications Trial. Arch Ophthalmol 1995; 113: 36–51.

    Article  Google Scholar 

  11. The_Diabetes Control and Complications Trial Research Group. Progression of retinopathy with intensive versus conventional treatment in the Diabetes Control and Complications Trial. Ophthalmology 1995; 102: 647–661.

    Google Scholar 

  12. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: The perspective of the Diabetes Control and Complications Trial. Diabetes 1996: 1289–1298.

    Google Scholar 

  13. The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 1996; 276: 1409–1415.

    Article  Google Scholar 

  14. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000; 342: 381–389.

    Article  Google Scholar 

  15. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. UKPDS 33. Lancet 1998; 352: 837–853.

    Article  Google Scholar 

  16. UK Prospective Diabetes Study Group. Effective of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352: 854–865.

    Article  Google Scholar 

  17. Gray A, Raikou M, McGuire A, et al. Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41). BMJ 2000; 320: 1373–1378.

    Article  PubMed  CAS  Google Scholar 

  18. American Diabetes Association. Position statement: Standards of medical care for patients with diabetes mellitus. Diabetes Care 1995; 19: 8–15.

    Google Scholar 

  19. Harris ML Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 2000; 23: 754–758.

    Article  PubMed  CAS  Google Scholar 

  20. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The medical management of hyperglycemia over a 10-year period in people with diabetes. Diabetes Care 1996; 19: 744–750.

    Article  PubMed  CAS  Google Scholar 

  21. Davis MD. Diabetic retinopathy, diabetic control, and blood pressure. Transplant Proc 1986; 18: 1565–1568.

    Google Scholar 

  22. Klein R, Klein BEK. Vision disorders in diabetes. In: Harris MI, Cowie CC, Stern MP, Boyko EJ, Reiber GE, Bennett PH (ed), Diabetes in America, 2nd Ed. National Institutes of Health NIH Publication No. 95-1468; 1995, pp 293–338.

    Google Scholar 

  23. Adler A, Stratton IM, Neil HAW, et al. Association of systolic blood pressure with macrovascular and microvascular complicaitons of type 2 diabetes (UKPDS 36): prospective observational study. B Med J 2000: 412–419.

    Google Scholar 

  24. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in Type 1 diabetes. Ophthalmology 1998; 105: 1801–1815.

    Article  PubMed  CAS  Google Scholar 

  25. Chaturvedi N, Sjolie, Stephenson JM, et al. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes: the EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998; 351: 28–31.

    Article  PubMed  CAS  Google Scholar 

  26. Chaturvedi N. Modulation of the renin-angiotensin system and retinopathy. Heart 2000; 84: i29–i31.

    Article  PubMed  Google Scholar 

  27. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in Type 2 diabetes. UKPDS 38. Br Med J 1998; 317: 703–713.

    Article  Google Scholar 

  28. Savage S, Johnson NL, Estacio RO, et al. The ABCD [Appropriate Blood Pressure Control in Diabetes] Trial: rationale and design of a trial of hypertension control (moderate or intensive) in Type II diabetes. Online Journal of Current Clinical Trials, Doc no. 104, 1993.

    Google Scholar 

  29. Duncan LJP, Cullen JF, Ireland JT, Nolan J, Oliver MF. A three-year trial of Atromid therapy in exudative diabetic retinopathy. Diabetes 1968; 17: 458–467.

    PubMed  CAS  Google Scholar 

  30. Klein BEK, Moss SE, Klein R, Suawicz TS. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIII: relationship of serum cholesterol to retinopathy and hard exudate. Ophthalmology 1991; 98: 1261–1265.

    PubMed  CAS  Google Scholar 

  31. Chew EY, Klein ML, Ferris FL III, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. ETDRS Report Number 22. Arch Ophthalmol 1996; 114: 1079–1084.

    Article  PubMed  CAS  Google Scholar 

  32. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor in diabetic retinopathy. Arch Ophthalmol 1990; 108: 1234–1244.

    Article  Google Scholar 

  33. Early Treatment Diabetic Retinopathy Study Research Group. Effects of aspirin treatment on diabetic retinopathy. ETDRS Report Number 8. Ophthamology 1991; 98: 757–765.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ophthalmology and Visual Sciences, University of Wisconsin, 610 North Walnut Street, WARF 460, Madison, Wisconsin, 53705

    Ronald I. Klein M.D. (Professor)

Authors
  1. Ronald I. Klein M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara E. K. Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Downstate Medical Center, State University of New York, New York, USA

    Eli A. Friedman M.D.

  2. Colombia University, New York, USA

    Francis A. L’Esperance Jr. M.D.

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Klein, R.I., Klein, B.E.K. (2002). Medical Approaches to Preventing Vision Loss from Diabetic Retinopathy. In: Friedman, E.A., L’Esperance, F.A. (eds) Diabetic Renal-Retinal Syndrome. Springer, Dordrecht. https://doi.org/10.1007/978-94-010-0614-9_7

Download citation

  • DOI: https://doi.org/10.1007/978-94-010-0614-9_7

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-3930-7

  • Online ISBN: 978-94-010-0614-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation